Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Overexpression of D-type cyclins, E2F-1, SV40 large T antigen and HPV16 E7 rescue cell cycle arrest of tsBN462 cells caused by the CCG1/TAFII250 mutation

Abstract

tsBN462 cells, which have a point mutation in CCG1/TAFII250, a component of TFIID complex, arrest in G1 at the nonpermissive temperature of 39.5°C. Overexpression of D-type cyclins rescued the cell cycle arrest of tsBN462 cells, suggesting that the cell cycle arrest was through Rb. Consistent with this, overexpression of E2F-1, whose function is repressed by the hypophosphorylated form of Rb, also rescued the cell cycle arrest. Moreover, expression of the viral oncoproteins SV40 large T antigen and HPV16 E7, which both bind Rb and inactivate its function, rescued the cell cycle arrest, whereas HPV16 E6 did not. Mutation of the Rb-binding motif in E7 abrogated its ability to rescue the cell cycle arrest. Expression of exogenous cyclin D1, SV40 large T antigen or CCG1/TAFII250 increased cyclin A expression at 39.5°C. Coexpression of HPV16 E7 and adenovirus E1b19K, which blocks apoptosis, rescued the proliferation of tsBN462 cells at 38.5°C. To investigate the mechanism underlying the lack of cyclin D1 expression, deletion analysis of cyclin D1 promoter was performed. The 0.15 kbp cyclin D1 core promoter region, which lacks any transcription factor binding motifs, still exhibited a temperature-sensitive phenotype in tsBN462 cells suggesting that CCG1/TAFII250 is critical for the function of the cyclin D1 core promoter.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Ariga H and Sugano S. . 1983 J. Virol. 48: 481–491.

  • Berezutskaya E and Bagchi S. . 1997 J. Biol. Chem. 272: 30135–30140.

  • Boyer SN, Wazer DE and Band V. . 1996 Cancer Res. 56: 4620–4624.

  • Brasier AR, Tate JE and Habener JF. . 1989 Biotechniques 7: 1116–1122.

  • Dikstein R, Ruppert S and Tjian R. . 1996 Cell 84: 781–790.

  • Dynlacht BD, Hoey T and Tjian R. . 1991 Cell 55: 563–576.

  • Gossen M and Bujard H. . 1992 Proc. Natl. Acad. Sci. USA 89: 5547–5551.

  • Hayashida T, Sekiguchi T, Noguchi E, Sunamoto H, Ohba T and Nishimoto T. . 1994 Gene 141: 267–270.

  • Herber B, Truss M, Beato M and Muller R. . 1994 Oncogene 9: 1295–1304.

  • Hisatake K, Hasegawa S, Takada R, Nakatani Y, Horikoshi M and Roeder R. . 1993 Nature 362: 179–181.

  • Hunter T and Pines J. . 1994 Cell 18: 573–582.

  • Kaelin WG, Krek W, Sellers WR, DeCaprio JA, Ajchenbaum F, Fuchs CS, Chittenden T, Li Y, Farnham PJ, Blanar MA, Livingston DM and Flemington EK. . 1992 Cell 70: 351–364.

  • Kokubo T, Takada R, Yamashita S, Gong DW, Roeder RG, Horikoshi M and Nakatani Y. . 1993 J. Biol. Chem. 268: 17554–17558.

  • Massimi P, Pim D and Banks L. . 1997 J. Gen. Virol. 78: 2607–2613.

  • Massimi P, Pim D, Storey A and Banks L. . 1996 Oncogene 12: 2325–2330.

  • Mizzen CA, Yang XJ, Kokubo T, Brownell JE, Bannister AJ, Owen HT, Workman J, Wang L, Berger SL, Kouzarides T, Nakatani Y and Allis CD. . 1996 Cell 87: 1261–1270.

  • Moqtaderi Z, Bai Y, Poon D, Weil PA and Struhl K. . 1996 Nature 383: 188–191.

  • Müller H, Lukas J, Schneider A, Warthoe P, Bartek J, Eilers M and Strauss M. . 1994 Proc. Natl. Acad. Sci. USA. 91: 2945–2949.

  • Nishimoto T, Sekiguchi T, Kai R, Yamashita K, Takahashi T and Sekiguchi M. . 1982 Somatic Cell Genet. 8: 811–824.

  • Oelgeschlager T, Chiang CM and Roeder RG. . 1996 Nature 382: 735–738.

  • Ruppert S, Edith HW and Tjian R. . 1993 Nature 362: 175–179.

  • Rushton JJ, Steinman RA and Robbins PD. . 1997 Cell Growth Diff. 8: 1099–1104.

  • Sekiguchi T and Hunter T. . 1998 Oncogene 16: 369–380.

  • Sekiguchi T, Nakashima T, Hayashida T, Kuraoka A, Hashimoto S, Tsuchida N, Shibata Y, Hunter T and Nishimoto T. . 1995 Exp. Cell Res. 218: 490–498.

  • Sekiguchi T, Noguchi E, Hayashida T, Nakashima T, Toyoshima H, Nishimoto T and Hunter T. . 1996 Genes Cells 1: 687–705.

  • Sekiguchi T, Nohiro Y, Nakamura Y, Hisamoto N and Nishimoto T. . 1991 Mol. Cell. Biol. 11: 3317–3325.

  • Sekiguchi T, Yoshida M, Sekiguchi M and Nishimoto T. . 1987 Exp. Cell Res. 169: 395–407.

  • Shao Z, Ruppert S and Robbins PD. . 1995 Proc. Natl. Acad. Sci. USA 92: 3115–3119.

  • Shao Z, Siegert JL, Ruppert S and Robbins PD. . 1997 Oncogene 15: 385–392.

  • Sherr CJ. . 1993 Cell 73: 1059–1065.

  • Sherr CJ. . 1996 Science 274: 1672–1677.

  • Sherr CJ and Roberts JM. . 1995 Genes Dev. 9: 1149–1163.

  • Smale ST. . 1997 Biochim. Biophys. Acta 1351: 73–88.

  • Suzuki YY, Guermah M and Roeder RG. . 1997 Mol. Cell. Biol. 17: 3284–3294.

  • Tanese N, Pugh BF and Tjian R. . 1991 Genes Dev. 5: 2212–2224.

  • Tooze J. . 1980 In: Molecuar Biology of Tumor Viruses. 2nd edn., Part 2. Cold Spring Harbor Laboratory: Cold Spring Harbor, NY.

    Google Scholar 

  • Verrijzer CP, Chen JL, Yokomori K and Tjian R. . 1995 Cell 81: 1115–1125.

  • Verrijzer CP and Tjian R. . 1996 Trends Biochem. Sci. 21: 338–342.

  • Walker SS, Reese JC, Apone LM and Green MR. . 1996 Nature 383: 185–188.

  • Walker SS, Shen WC, Reese JC, Apone LM and Green MR. . 1997 Cell 90: 607–614.

  • Wang EH, Zou S and Tjian R. . 1997 Genes Dev. 11: 2658–2669.

  • Yamamoto M, Yoshida M, Ono K, Fujita T, Ohtani-Fujita N, Sakai T and Nikaido T. . 1994 Exp. Cell Res. 210: 94–101.

Download references

Acknowledgements

We thank the members of the Hunter/Eckhart laboratory and Nishimoto laboratory for help and discussions. We thank J Fukumura for technical assistance. We thank D Chambers for his help with FACScan analysis. This work was supported by a grant-in-aid for scientific and cancer research from the Ministry of Education, Science and Culture of Japan (TS, TN) and by USPHS grants CA14195 and CA39780 (TH). TH is a Frank and Else Schilling American Cancer Society Research Professor.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sekiguchi, T., Nishimoto, T. & Hunter, T. Overexpression of D-type cyclins, E2F-1, SV40 large T antigen and HPV16 E7 rescue cell cycle arrest of tsBN462 cells caused by the CCG1/TAFII250 mutation. Oncogene 18, 1797–1806 (1999). https://doi.org/10.1038/sj.onc.1202508

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.onc.1202508

Keywords

This article is cited by

Search

Quick links